Zhu YJ - Search Results

1

Comparison of the diagnostic performance of ¹⁸F-fluorothymidine versus ¹⁸F-fluorodeoxyglucose positron emission tomography on pulmonary lesions: A meta analysis.

Li XF, Dai D, Song XY, Liu JJ, Zhu YJ, Xu WG. Li XF, et al. Among authors: zhu yj. Mol Clin Oncol. 2015 Jan;3(1):101-108. doi: 10.3892/mco.2014.440. Epub 2014 Oct 9. Mol Clin Oncol. 2015. PMID: 25469278 Free PMC article.

2

Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary.

Yu X, Li X, Song X, Dai D, Zhu L, Zhu Y, Wang J, Zhao H, Xu W. Yu X, et al. Oncol Lett. 2016 Nov;12(5):3785-3792. doi: 10.3892/ol.2016.5203. Epub 2016 Sep 29. Oncol Lett. 2016. PMID: 27895731 Free PMC article.

3

Application and Indication of Carcinoembryonic Antigen Triggered 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Detection of Relapse of Colorectal Cancer Patients After Curative Therapy.

Yu X, Zhu L, Dai D, Song X, Chen W, Zhu Y, Li X, Xu W. Yu X, et al. J Comput Assist Tomogr. 2017 Sep/Oct;41(5):719-725. doi: 10.1097/RCT.0000000000000601. J Comput Assist Tomogr. 2017. PMID: 28481810

4

Quantitative ¹⁸F-FDG PET analysis in survival rate prediction of patients with non-small cell lung cancer.

Ma W, Wang M, Li X, Huang H, Zhu Y, Song X, Dai D, Xu W. Ma W, et al. Oncol Lett. 2018 Oct;16(4):4129-4136. doi: 10.3892/ol.2018.9166. Epub 2018 Jul 18. Oncol Lett. 2018. PMID: 30214552 Free PMC article.

5

Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer.

Yu X, Zhu Y, Wang J, Song X, Zhu L, Men X, Li X, Dai D, Xu W. Yu X, et al. Nucl Med Commun. 2017 Feb;38(2):193-200. doi: 10.1097/MNM.0000000000000637. Nucl Med Commun. 2017. PMID: 27977537

6

[Current Status and Progress in Molecular Imaging of Non-small Cell Lung  Cancer for Molecular Targeted EGFR-TKI Treatment Sensitivity and  Treatment Tolerance Prediction].

Dai D, Xu W, Wang Q, Li X, Zhu Y. Dai D, et al. Zhongguo Fei Ai Za Zhi. 2017 Dec 20;20(12):852-856. doi: 10.3779/j.issn.1009-3419.2017.12.10. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29277186 Free PMC article. Review. Chinese.

7

CD147-mediated glucose metabolic regulation contributes to the predictive role of ¹⁸ F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC.

Li X, Fu Q, Zhu Y, Wang J, Liu J, Yu X, Xu W. Li X, et al. Mol Carcinog. 2019 Feb;58(2):247-257. doi: 10.1002/mc.22923. Epub 2018 Oct 25. Mol Carcinog. 2019. PMID: 30320488

8

Enhanced glucose metabolism mediated by CD147 is associated with ¹⁸ F-FDG PET/CT imaging in lung adenocarcinoma.

Zhang Y, Liu J, Sun Y, Yu X, Wang J, Dai D, Zhu Y, Song X, Zhu L, Li X, Xu W. Zhang Y, et al. Thorac Cancer. 2020 May;11(5):1245-1257. doi: 10.1111/1759-7714.13383. Epub 2020 Mar 11. Thorac Cancer. 2020. PMID: 32162491 Free PMC article.

9

[Clinical significance of (18)F-FDG PET/CT evaluation of response to treatment in T-cell lymphoma].

Cheng J, Yang XY, Xu WG, Song XY, Dai D, Zhu YJ. Cheng J, et al. Among authors: zhu yj. Zhonghua Xue Ye Xue Za Zhi. 2012 Jan;33(1):16-9. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22575186 Chinese.

10

Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients.

Dai D, Li XF, Wang J, Liu JJ, Zhu YJ, Zhang Y, Wang Q, Xu WG. Dai D, et al. Among authors: zhu yj. Int J Cancer. 2016 Feb 15;138(4):1003-12. doi: 10.1002/ijc.29832. Epub 2015 Sep 22. Int J Cancer. 2016. PMID: 26334931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

936 results

Search Page

Filters